AR230730A1 - Procedimiento para preparar una suspension acuosa de oxendolona - Google Patents
Procedimiento para preparar una suspension acuosa de oxendolonaInfo
- Publication number
- AR230730A1 AR230730A1 AR290244A AR29024482A AR230730A1 AR 230730 A1 AR230730 A1 AR 230730A1 AR 290244 A AR290244 A AR 290244A AR 29024482 A AR29024482 A AR 29024482A AR 230730 A1 AR230730 A1 AR 230730A1
- Authority
- AR
- Argentina
- Prior art keywords
- oxendolone
- preparing
- procedure
- water suspension
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56129517A JPS5832899A (ja) | 1981-08-18 | 1981-08-18 | オキセンドロン水性懸濁剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR230730A1 true AR230730A1 (es) | 1984-06-29 |
Family
ID=15011450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR290244A AR230730A1 (es) | 1981-08-18 | 1982-08-06 | Procedimiento para preparar una suspension acuosa de oxendolona |
Country Status (13)
Country | Link |
---|---|
US (1) | US4462996A (es) |
EP (1) | EP0072662B1 (es) |
JP (1) | JPS5832899A (es) |
KR (1) | KR880001806B1 (es) |
AR (1) | AR230730A1 (es) |
CA (1) | CA1176983A (es) |
DE (1) | DE3263754D1 (es) |
ES (1) | ES515057A0 (es) |
GR (1) | GR76258B (es) |
HK (1) | HK23888A (es) |
MY (1) | MY8700654A (es) |
PT (1) | PT75435B (es) |
SG (1) | SG110187G (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4120311A1 (de) * | 1991-06-20 | 1992-12-24 | Kali Chemie Pharma Gmbh | Konservierte pharmazeutische zubereitungen |
US20050032811A1 (en) * | 2003-08-06 | 2005-02-10 | Josiah Brown | Methods for administering aripiprazole |
ATE411797T2 (de) * | 2003-10-23 | 2008-11-15 | Otsuka Pharma Co Ltd | Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren |
EP1933814A2 (en) * | 2005-09-15 | 2008-06-25 | Elan Pharma International Limited | Nanoparticulate aripiprazole formulations |
NZ582415A (en) * | 2007-07-31 | 2012-05-25 | Otsuka Pharma Co Ltd | Methods for producing aripiprazole suspension and freeze-dried formulation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2861920A (en) * | 1954-05-04 | 1958-11-25 | Upjohn Co | Therapeutic suspensions of steroids containing pvp and/or pva |
US3856829A (en) * | 1970-01-07 | 1974-12-24 | Takeda Chemical Industries Ltd | 16{62 -hydrocarbon substituted estrane compounds |
JPS4832643A (es) * | 1971-09-02 | 1973-05-01 | ||
JPS4966815A (es) * | 1972-10-25 | 1974-06-28 |
-
1981
- 1981-08-18 JP JP56129517A patent/JPS5832899A/ja active Granted
-
1982
- 1982-08-06 AR AR290244A patent/AR230730A1/es active
- 1982-08-09 US US06/406,460 patent/US4462996A/en not_active Expired - Lifetime
- 1982-08-11 DE DE8282304238T patent/DE3263754D1/de not_active Expired
- 1982-08-11 EP EP82304238A patent/EP0072662B1/en not_active Expired
- 1982-08-13 GR GR69042A patent/GR76258B/el unknown
- 1982-08-17 CA CA000409562A patent/CA1176983A/en not_active Expired
- 1982-08-17 PT PT75435A patent/PT75435B/pt not_active IP Right Cessation
- 1982-08-17 KR KR8203686A patent/KR880001806B1/ko active
- 1982-08-17 ES ES515057A patent/ES515057A0/es active Granted
-
1987
- 1987-12-26 SG SG1101/87A patent/SG110187G/en unknown
- 1987-12-30 MY MY654/87A patent/MY8700654A/xx unknown
-
1988
- 1988-03-30 HK HK238/88A patent/HK23888A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1176983A (en) | 1984-10-30 |
SG110187G (en) | 1988-05-20 |
JPS5832899A (ja) | 1983-02-25 |
HK23888A (en) | 1988-04-08 |
GR76258B (es) | 1984-08-04 |
DE3263754D1 (en) | 1985-06-27 |
ES8403719A1 (es) | 1984-04-01 |
MY8700654A (en) | 1987-12-31 |
ES515057A0 (es) | 1984-04-01 |
KR840000901A (ko) | 1984-03-26 |
US4462996A (en) | 1984-07-31 |
EP0072662A2 (en) | 1983-02-23 |
JPS6361957B2 (es) | 1988-11-30 |
EP0072662A3 (en) | 1983-08-24 |
PT75435B (pt) | 1985-05-31 |
KR880001806B1 (ko) | 1988-09-19 |
PT75435A (pt) | 1982-09-01 |
EP0072662B1 (en) | 1985-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES539563A0 (es) | Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol | |
ES519031A0 (es) | Un procedimiento para preparar derivados de fenilciclobutano. | |
ES518276A0 (es) | Un procedimiento para preparar nuevos derivados de tienopirimidina. | |
ES529349A0 (es) | Un procedimiento para la preparacion de derivados de acilmorfinano | |
ES525886A0 (es) | Un procedimiento para preparar derivados de propinilaminoisoxazol | |
DK284888D0 (da) | Fremgangsmaade til fremstilling af en vandig suspension af anitrificerende bakterier | |
ES539000A0 (es) | Un procedimiento para preparar un derivado de una enzima fibronolitica | |
ES524922A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno | |
MX7466E (es) | Procedimiento para preparar una composicion surfactante de almidon | |
ES512852A0 (es) | "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida". | |
MX7528E (es) | Procedimiento para la preparacion de una vacuna sintetica | |
ES546061A0 (es) | Un procedimiento para preparar un derivado de uridina | |
ES552910A0 (es) | Un procedimiento para preparar derivados de indol | |
ES537349A0 (es) | Un procedimiento para la preparacion de un aminotiol cuaternario | |
BR8202085A (pt) | Processo para a preparacao de derivados de piperazina | |
ES527795A0 (es) | Un procedimiento para preparar derivados de propinilaminotiazol | |
AR230730A1 (es) | Procedimiento para preparar una suspension acuosa de oxendolona | |
RO85387A (ro) | Procedeu de preparare a stereospecifica a 5-fenil-2s-pentanolului | |
MX7600E (es) | Procedimiento para elaborar alcanoles | |
ES518347A0 (es) | Un procedimiento para la preparacion de derivados de desoxiuridina | |
ES526149A0 (es) | Un procedimiento para la preparacion de derivados de espirotiazolidinil-piperazina | |
ES546574A0 (es) | Procedimiento para preparar derivados de saframicina a | |
ES528985A0 (es) | Un procedimiento para la preparacion de una b- lactama | |
ES537098A0 (es) | Un procedimiento para preparar derivados de tiadiazina | |
ES526647A0 (es) | Metodo de preparar derivados de p-acilaminofenol |